India has suspended a drugmaker’s manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday. Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has damaged India’s image as the “pharmacy of the world” providing affordable drugs globally.
Recent Posts
- DFS secretary reviews vision strategy of LIC and GIC Re
- Domestic demand lifts commercial vehicle sales in April, export pressures persist
- RBI and IRDAI not inclined to allow commodity derivatives, Sebi says
- Washington’s ‘Project Freedom’ to steer foreign stranded ships to safety through Strait of Hormuz
- Trump likely to reject Iran’s peace proposal
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits